Schedule 13D ownership disclosure

SCICLONE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 80862K104

Event date: 2017-02-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-009705
Form type
SC 13D/A
Filer
GL Partners Capital Management Ltd
CIK
CIK 1562291
Filed
Feb 17, 2017
Reporting period
Feb 17, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub